Ninety One UK Ltd Has $44.73 Million Stake in CME Group Inc. (NASDAQ:CME)

Ninety One UK Ltd trimmed its stake in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 3.6% during the fourth quarter, Holdings Channel.com reports. The firm owned 212,368 shares of the financial services provider’s stock after selling 7,904 shares during the period. Ninety One UK Ltd’s holdings in CME Group were worth $44,725,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Capital Advisors Ltd. LLC lifted its holdings in CME Group by 5.0% in the third quarter. Capital Advisors Ltd. LLC now owns 1,032 shares of the financial services provider’s stock valued at $207,000 after buying an additional 49 shares during the period. West Family Investments Inc. lifted its holdings in CME Group by 3.4% in the second quarter. West Family Investments Inc. now owns 1,503 shares of the financial services provider’s stock valued at $278,000 after buying an additional 50 shares during the period. Jaffetilchin Investment Partners LLC lifted its holdings in CME Group by 1.7% in the third quarter. Jaffetilchin Investment Partners LLC now owns 3,022 shares of the financial services provider’s stock valued at $605,000 after buying an additional 51 shares during the period. Fidelis Capital Partners LLC lifted its holdings in CME Group by 3.9% in the third quarter. Fidelis Capital Partners LLC now owns 1,400 shares of the financial services provider’s stock valued at $280,000 after buying an additional 52 shares during the period. Finally, Thrivent Financial for Lutherans raised its holdings in CME Group by 0.3% in the second quarter. Thrivent Financial for Lutherans now owns 15,841 shares of the financial services provider’s stock worth $3,243,000 after purchasing an additional 52 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

CME has been the topic of several analyst reports. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $210.00 target price (down from $235.00) on shares of CME Group in a report on Friday, April 5th. Rosenblatt Securities reissued a “sell” rating and set a $180.00 price objective on shares of CME Group in a research report on Thursday, January 4th. Keefe, Bruyette & Woods reissued a “market perform” rating and set a $229.00 price objective on shares of CME Group in a research report on Wednesday, April 3rd. Argus increased their price objective on shares of CME Group from $225.00 to $245.00 and gave the stock a “buy” rating in a research report on Wednesday, March 6th. Finally, The Goldman Sachs Group lowered shares of CME Group from a “neutral” rating to a “sell” rating and set a $195.00 price target on the stock. in a research note on Wednesday, January 3rd. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company. According to MarketBeat, CME Group currently has an average rating of “Hold” and a consensus price target of $215.70.

View Our Latest Research Report on CME Group

CME Group Stock Up 0.6 %

Shares of CME stock opened at $209.65 on Friday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 1 year low of $175.73 and a 1 year high of $223.80. The firm’s fifty day moving average price is $214.26 and its two-hundred day moving average price is $211.61. The firm has a market capitalization of $75.47 billion, a P/E ratio of 23.64, a PEG ratio of 5.92 and a beta of 0.49.

CME Group (NASDAQ:CMEGet Free Report) last released its quarterly earnings data on Wednesday, February 14th. The financial services provider reported $2.37 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.10. The company had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.43 billion. CME Group had a net margin of 57.83% and a return on equity of 12.32%. CME Group’s revenue for the quarter was up 19.2% compared to the same quarter last year. During the same period in the previous year, the business earned $1.92 EPS. On average, equities analysts predict that CME Group Inc. will post 9.56 EPS for the current fiscal year.

CME Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 26th. Stockholders of record on Friday, March 8th were paid a dividend of $1.15 per share. The ex-dividend date was Thursday, March 7th. This is a positive change from CME Group’s previous quarterly dividend of $1.10. This represents a $4.60 annualized dividend and a dividend yield of 2.19%. CME Group’s payout ratio is currently 51.86%.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Recommended Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.